TSVT - 2Seventy Bio Inc. (TSVT) Q4 2023 Earnings Call Transcript

2024-03-05 12:57:03 ET

2Seventy Bio, Inc. (TSVT)

Q4 2023 Earnings Conference Call

March 05, 2024, 08:00 ET

Company Participants

Elizabeth Hickin - Head, IR

Chip Baird - Incoming CEO

Vicki Eatwell - Incoming CFO

Anna Truppel-Hartmann - SVP, Clinical Development

Conference Call Participants

Daina Graybosch - Leerink Partners

Tommie Reerink - Goldman Sachs & Co.

Kelsey Goodwin - Guggenheim Securities

Samantha Semenkow - Citigroup

Presentation

Operator

Good day, and thank you for standing by. Welcome to the 2seventy bio fourth-quarter 2023 earnings conference call. [Operator Instructions].

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Elizabeth Hickin, Head of Investor Relations. Please go ahead....

For further details see: